|

BCG for Therapeutic Use Clinical Trials

2 actively recruiting trials

Also known as: BCG

Pipeline

Phase 3: 2

Top Sponsors

  • Chengdu CoenBiotech Co., Ltd1
  • Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1

Indications

  • Cancer2
  • BCG1
  • Non-Muscle Invasive Bladder Cancer1

Other2 trials

BCG for Therapeutic Use Phase Ⅲ Clinical Trial
Phase 3
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.